Determination of the efficacy of cryotherapy plus topical Juniperus excelsa M.Bieb, based on traditional Persian medicine, versus cryotherapy alone in the treatment of cutaneous leishmaniasis: a double-blind randomized clinical trial
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
Introduction: Cutaneous leishmaniasis is one of the highly prevalent endemic diseases in the Middle East and North Africa. Many treatment modalities have been recommended for this condition but success rates remain limited. Herbal remedies have also been used for treatment but evidence-based clinical trials with these products are sparse. In-vitro and in-vivo studies have shown the anti-leishmanial and curative effects of extract of fruits and leaves of Juniperus excelsa (J. excelsa). The aim of this study was to determine the efficacy of topical J. excelsa M. Bieb extract as an adjuvant to cryotherapy for the treatment of human CL. Materials and Methods: This study was designed as a two-arm triple-blind randomized placebo-controlled clinical trial using a parallel design. Seventy-two patients with clinical diagnosis of CL confirmed by leishmania smears were allocated to receive either a topical formulation of leaf of J. excelsa extract (group A) or placebo (group B) for 3 months. Both groups received cryotherapy as baseline standard treatment. Patients were evaluated before and weekly after the intervention was initiated until complete cure. Results: Overall, 82% of patients in group A, experienced complete cure and 9% of them had partial cure. On the other hand, 34% in group B reported complete cure, while 14% of them had partial cure at the end of treatment protocol with a significant difference between the two groups (p< 0.001). The mean duration to healing of the lesions in patients who received J. excelsa extract was statistically significantly shorter than the placebo group (p=0.04). No significant side effect was seen in the J. excelsa extract group except for mild to moderate local irritation after a few weeks in a few numbers of patients. Conclusion: The results of this study showed that topical J. excelsa extract can be used as an adjuvant treatment modality in addition to cryotherapy for accelerating the time to cure in addition to increasing the complete cure rate in CL. Key Words: cutaneous leishmaniasis, Juniperus excelsa, Traditional Persian Medicine, herbal medicine, cryotherapy.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years(—)
- 性别
- All
入选标准
- •Age 18 to 70 years the maximum
- •The maximum duration of their involvement by leishmaniasis is 4 months
- •Having physical health except the cutaneous leishmaniasis infection
- •Having 4 or less of the lesion leishmaniasis lesions
- •Did not taking any of topical and systemic anti-Leishmania treatment during last 4 weeks
- •Cutaneous leishmaniasis is approved of by smear
排除标准
- •Patients with complex forms of leishmaniasis and symptoms of mucousal leishmaniasis
- •Having more than 4 lesions
- •The lesions greater than 5 cm
- •Sub-cutaneous nodules
- •Regional adenopaty if greater than 1 cm size
- •Patients with immunodeficiency disease
- •The infants and children less than 18 years
- •Women in lactation and pregnancy
- •Patients with satellite lesions or sporotrichoid lesions
- •Patients with facial cutaneous leishmaniasis lesions
